All
CX-2051 Proves Safe and Effective in Advanced Colon Cancer
CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data from the CTMX-2051-101 study.
Long-Term Prostate Cancer Data Highlights Risk and Survivorship Needs
Researchers followed patients for years and found that the risk of dying from prostate cancer depended on how aggressive the cancer was at diagnosis.
FDA Approves Emrelis in Previously Treated, Advanced NSCLC
The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met protein overexpression.
Survivors of Breast Cancer May Still Struggle with Fear of Recurrence
Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those thoughts at bay.
FDA Approves Welireg for Pheochromocytoma and Paraganglioma
The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic pheochromocytoma or paraganglioma.
Aidixi Combination Therapy Improves Survival in Urothelial Carcinoma
Aidixi plus toripalimab met progression-free and overall survival study end points versus chemo for patients with HER2-expressing urothelial carcinoma.
Bone Metastasis Count May Guide Erleada Treatment in Prostate Cancer
The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases.
My Rare Cancer Gave Me Permission to Live
After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now.
Why Relationships are Key When Caring For Patients With MPNs
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
Understanding the Unique Task of Treating Older Patients With Breast Cancer
Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease.
I Found Strength After Surviving Multiple Myeloma and Through Recovery
I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality.
Custom-Made Vaccine Combo Proves Effective in Bladder Cancer
Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, eliciting a strong immune response.
Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer
Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer.
Cracked, Not Broken: Life After Breast Cancer
Breast cancer cracked me open but didn’t break me — it gave me voice, purpose and courage to dream boldly, live fully and speak up for those who can’t.
Inspirational Leader Shines Her Light Outward to Others
Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer.
Advances in Radiation Improve Precision in Brain Cancer Therapy
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Finding Strength and Joy During My Stage 4 Kidney Cancer Experience
Living with stage 4 kidney cancer has taught me to embrace the present, cherish connection and find gratitude each day in unexpected places.
IHC Testing Aims to Expand Personalized Treatment in Lung Cancer
Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address unmet needs in NSCLC treatment.
Lymphedema Makes Summer Preparations Challenging After Breast Cancer
Summer heat can worsen my lymphedema, but I’ve learned simple ways to stay cool, reduce swelling and protect my arms — here’s what helps me most.
Understanding the Evolving Strategies in WM Care and Management
An expert reflects on the treatment landscape of Waldenström macroglobulinemia, emphasizing diagnostics, collaboration and managing neuropathy effectively.
My Health, My Voice: Why Self-Advocacy Is Important
I challenged a mistaken fall risk label before my transplant and proved that self-advocacy is crucial to both quality care and emotional well-being.
A Lifelong Advocate and Innovator
Mary Anderson, B.S.N., RN, OCN, embodies the spirit of an Extraordinary Healer.
When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound
A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.
Personalized Breast Cancer Care for Older Adults Goes Beyond Age
Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older patients with breast cancer.
Unmatched Energy, Every Single Day
For the past 2 years, I have worked alongside Carmela Cuccurullo, NP.
Expert Shares Key Insights During Melanoma Awareness Month
For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.
Understanding AYA Lymphoma Care and Why Treatment May Differ by Age
Dr. Andrew M. Evens breaks down what it means to be an adolescent or young adult with lymphoma and how treatment differs from pediatric and adult care.
A Thank You to Nurses and the Support That Lasts Beyond Cancer Care
After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.
Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer
Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer
Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for some with bladder cancer.
